Image Analysis
Lumea, dedicated to advancing tissue standardization and digital pathology, solidified its position in the United States in the latest KLAS Research LEHI, UTAH, USA, February 8, 2024 /EINPresswire.com/ — Lumea, a trailblazing digital...
Corista: DP3’s momentum as a world-class integrated pathology solution grows Concord, MA (Feb. 7, 2024) – Corista, a leader in digital pathology solutions, is excited to announce that it has received a Class II Medical Device License...
Qritive Secures Multi-Year Contracts to Drive AI Adoption in Pathology Across India MUMBAI, India & SINGAPORE--(BUSINESS WIRE)--QritiveTM, a leading provider of AI solutions for pathology labs worldwide, announces partnership with...
ArteraAI: The funding will support the international expansion and commercial growth of the company and its first-of-its-kind test SAN FRANCISCO--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence (MMAI) based...
Read the latest publication from RareCyte. Journal of Clinical Oncology: Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)1 ICI therapy Understanding the mechanisms of acquired resistance...
From HIT Consultant regarding PathAI: What You Should Know: PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. The expansion...
